CD99 triggers upregulation of miR-9-modulated PRDM1/BLIMP1 in Hodgkin/Reed-Sternberg cells and induces redifferentiation

International Journal of Cancer

Volumn 131, Issue 4, 2012, Pages

  Huang, Xueping ^a   Zhou, Xinhua ^a   Wang, Zhiqiang ^a   Li, Feng ^a   Liu, Fanrong ^a   Zhong, Lin ^a   Li, Xiangzhao ^a   Han, Xiqun ^a   Wu, Ziqing ^a   Chen, Shaohong ^a   Zhao, Tong ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

CD99; classical Hodgkin lymphoma; differentiation; miR 9; PRDM1; terminal B cells

Indexed keywords

B LYMPHOCYTE INDUCED MATURATION PROTEIN 1; CD15 ANTIGEN; CD19 ANTIGEN; CD30 ANTIGEN; CD38 ANTIGEN; CD79 ANTIGEN; CD79ALPHA ANTIGEN; CD99 ANTIGEN; MICRORNA 9; TRANSCRIPTION FACTOR PAX5; UNCLASSIFIED DRUG;

ACTIN FILAMENT; ARTICLE; CANCER CELL CULTURE; CELL DIFFERENTIATION; CELL GROWTH; CELL STRUCTURE; CLASSICAL HODGKIN LYMPHOMA; DISEASE MARKER; DOWN REGULATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; PLASMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; REED STERNBERG CELL; TUMOR GROWTH; UPREGULATION;

ANTIGENS, CD; BASE SEQUENCE; BLOTTING, WESTERN; CELL ADHESION MOLECULES; CELL DIFFERENTIATION; CELL LINE, TUMOR; DNA PRIMERS; FLOW CYTOMETRY; HODGKIN DISEASE; HUMANS; IMMUNOMAGNETIC SEPARATION; IN SITU HYBRIDIZATION; MICRORNAS; REED-STERNBERG CELLS; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UP-REGULATION;

EID: 84862585229     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.26503     Document Type: Article

References (44)

1. Buettner M, Greiner A, Avramidou A, Jack HM, Niedobitek G,. Evidence of abortive plasma cell differentiation in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma. Hematol Oncol 2005; 23: 127-32. (Pubitemid 43061890)
2. Nie K, Gomez M, Landgraf P, Garcia JF, Liu Y, Tan LH, Chadburn A, Tuschl T, Knowles DM, Tam W,. MicroRNA-mediated down-regulation of PRDM1/Blimp-1 in Hodgkin/Reed-Sternberg cells: a potential pathogenetic lesion in Hodgkin lymphomas. Am J Pathol 2008; 173: 242-52. (Pubitemid 351947971)
3. Leucci E, Onnis A, Cocco M, De Falco G, Imperatore F, Giuseppina A, Costanzo V, Cerino G, Mannucci S, Cantisani R, Nyagol J, Mwanda W, et al. B-cell differentiation in EBV-positive Burkitt lymphoma is impaired at posttranscriptional level by miRNA-altered expression. Int J Cancer 2010; 126: 1316-26.
4. Nie K, Zhang T, Allawi H, Gomez M, Liu Y, Chadburn A, Wang YL, Knowles DM, Tam W,. Epigenetic down-regulation of the tumor suppressor gene PRDM1/Blimp-1 in diffuse large B cell lymphomas: a potential role of the microRNA let-7. Am J Pathol 2010; 177: 1470-9.
5. Shapiro-Shelef M, Lin KI, McHeyzer-Williams LJ, Liao J, McHeyzer-Williams MG, Calame K,. Blimp-1 is required for the formation of immunoglobulin secreting plasma cells and pre-plasma memory B cells. Immunity 2003; 19: 607-20. (Pubitemid 37311441)
6. Martins G, Calame K,. Regulation and functions of Blimp-1 in T and B lymphocytes. Annu Rev Immunol 2008; 26: 133-69. (Pubitemid 351600373)
7. Johnston RJ, Poholek AC, DiToro D, Yusuf I, Eto D, Barnett B, Dent AL, Craft J, Crotty S,. Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation. Science 2009; 325: 1006-10.
8. Rutishauser RL, Martins GA, Kalachikov S, Chandele A, Parish IA, Meffre E, Jacob J, Calame K, Kaech SM,. Transcriptional repressor Blimp-1 promotes CD8(+) T cell terminal differentiation and represses the acquisition of central memory T cell properties. Immunity 2009; 31: 296-308.
9. Chang DH, Angelin-Duclos C, Calame K,. BLIMP-1: trigger for differentiation of myeloid lineage. Nat Immunol 2000; 1: 169-76.
10. Chan YH, Chiang MF, Tsai YC, Su ST, Chen MH, Hou MS, Lin KI,. Absence of the transcriptional repressor Blimp-1 in hematopoietic lineages reveals its role in dendritic cell homeostatic development and function. J Immunol 2009; 183: 7039-46.
11. Kallies A, Carotta S, Huntington ND, Bernard NJ, Tarlinton DM, Smyth MJ, Nutt SL,. A role for Blimp-1 in the transcriptional network controlling natural killer cell maturation. Blood 2010; 117: 1869-79.
12. Vasanwala FH, Kusam S, Toney LM, Dent AL,. Repression of AP-1 function: a mechanism for the regulation of Blimp-1 expression and B lymphocyte differentiation by the B cell lymphoma-6 protooncogene. J Immunol 2002; 169: 1922-9. (Pubitemid 34857655)
13. Klein U, Casola S, Cattoretti G, Shen Q, Lia M, Mo T, Ludwig T, Rajewsky K, Dalla-Favera R,. Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination. Nat Immunol 2006; 7: 773-82. (Pubitemid 43905877)
14. Kovar H, Dworzak M, Strehl S, Schnell E, Ambros IM, Ambros PF, Gadner H,. Overexpression of the pseudoautosomal gene MIC2 in Ewing's sarcoma and peripheral primitive neuroectodermal tumor. Oncogene 1990; 5: 1067-70.
15. Dworzak MN, Fritsch G, Buchinger P, Fleischer C, Printz D, Zellner A, Schollhammer A, Steiner G, Ambros PF, Gadner H,. Flow cytometric assessment of human MIC2 expression in bone marrow, thymus, and peripheral blood. Blood 1994; 83: 415-25. (Pubitemid 24030567)
16. Buxton D, Bacchi CE, Gualco G, Weiss LM, Zuppan CW, Rowsell EH, Huang Q, Wang J,. Frequent expression of CD99 in anaplastic large cell lymphoma: a clinicopathologic and immunohistochemical study of 160 cases. Am J Clin Pathol 2009; 131: 574-9.
17. Alberti I, Bernard G, Rouquette-Jazdanian AK, Pelassy C, Pourtein M, Aussel C, Bernard A,. CD99 isoforms expression dictates T cell functional outcomes. FASEB J 2002; 16: 1946-8.
18. Schenkel AR, Mamdouh Z, Chen X, Liebman RM, Muller WA,. CD99 plays a major role in the migration of monocytes through endothelial junctions. Nat Immunol 2002; 3: 143-50. (Pubitemid 34141444)
19. Cerisano V, Aalto Y, Perdichizzi S, Bernard G, Manara MC, Benini S, Cenacchi G, Preda P, Lattanzi G, Nagy B, Knuutila S, Colombo MP, et al. Molecular mechanisms of CD99-induced caspase-independent cell death and cell-cell adhesion in Ewing's sarcoma cells: actin and zyxin as key intracellular mediators. Oncogene 2004; 23: 5664-74. (Pubitemid 39093044)
20. Rocchi A, Manara MC, Sciandra M, Zambelli D, Nardi F, Nicoletti G, Garofalo C, Meschini S, Astolfi A, Colombo MP, Lessnick SL, Picci P, et al. CD99 inhibits neural differentiation of human Ewing sarcoma cells and thereby contributes to oncogenesis. J Clin Invest 2010; 120: 668-80.
21. Husak Z, Printz D, Schumich A, Potschger U, Dworzak MN,. Death induction by CD99 ligation in TEL/AML1-positive acute lymphoblastic leukemia and normal B cell precursors. J Leukoc Biol 2010; 88: 405-12.
22. Kim SH, Choi EY, Shin YK, Kim TJ, Chung DH, Chang SI, Kim NK, Park SH,. Generation of cells with Hodgkin's and Reed-Sternberg phenotype through downregulation of CD99 (Mic2). Blood 1998; 92: 4287-95. (Pubitemid 28544346)
23. Kim SH, Shin YK, Lee IS, Bae YM, Sohn HW, Suh YH, Ree HJ, Rowe M, Park SH,. Viral latent membrane protein 1 (LMP-1)-induced CD99 down-regulation in B cells leads to the generation of cells with Hodgkin's and Reed-Sternberg phenotype. Blood 2000; 95: 294-300. (Pubitemid 30017255)
24. Xiao C, Calado DP, Galler G, Thai TH, Patterson HC, Wang J, Rajewsky N, Bender TP, Rajewsky K,. MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell 2007; 131: 146-59. (Pubitemid 47498525)
25. Ventura A, Young AG, Winslow MM, Lintault L, Meissner A, Erkeland SJ, Newman J, Bronson RT, Crowley D, Stone JR, Jaenisch R, Sharp PA, et al. Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell 2008; 132: 875-86. (Pubitemid 351312807)
26. Navarro A, Gaya A, Martinez A, Urbano-Ispizua A, Pons A, Balague O, Gel B, Abrisqueta P, Lopez-Guillermo A, Artells R, Montserrat E, Monzo M,. MicroRNA expression profiling in classic Hodgkin lymphoma. Blood 2008; 111: 2825-32.
27. Medina PP, Nolde M, Slack FJ,. OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. Nature 2010; 467: 86-90.
28. Zhang J, Jima DD, Jacobs C, Fischer R, Gottwein E, Huang G, Lugar PL, Lagoo AS, Rizzieri DA, Friedman DR, Weinberg JB, Lipsky PE, et al. Patterns of microRNA expression characterize stages of human B-cell differentiation. Blood 2009; 113: 4586-94.
29. Huang ZP, He Y, Zhou XH, Han XQ, Wu ZQ, Zhang Y, Wen ZH, Zhao T,. Construction of mic2/CD99 gene vector and its transfection in Hodgkin lymphoma L428 cell line. Nan Fang Yi Ke Da Xue Xue Bao 2009; 29: 2407-9.
30. Cattoretti G, Angelin-Duclos C, Shaknovich R, Zhou H, Wang D, Alobeid B,. PRDM1/Blimp-1 is expressed in human B-lymphocytes committed to the plasma cell lineage. J Pathol 2005; 206: 76-86. (Pubitemid 40613437)
31. Garcia JF, Roncador G, Sanz AI, Maestre L, Lucas E, Montes-Moreno S, Fernandez Victoria R, Martinez-Torrecuadrara JL, Marafioti T, Mason DY, Piris MA,. PRDM1/BLIMP-1 expression in multiple B and T-cell lymphoma. Haematologica 2006; 91: 467-74.
32. Valsami S, Pappa V, Rontogianni D, Kontsioti F, Papageorgiou E, Dervenoulas J, Karmiris T, Papageorgiou S, Harhalakis N, Xiros N, Nikiforakis E, Economopoulos T,. A clinicopathological study of B-cell differentiation markers and transcription factors in classical Hodgkin's lymphoma: a potential prognostic role of MUM1/IRF4. Haematologica 2007; 92: 1343-50. (Pubitemid 350144151)
33. Nutt SL, Fairfax KA, Kallies A,. BLIMP1 guides the fate of effector B and T cells. Nat Rev Immunol 2007; 7: 923-7. (Pubitemid 350166060)
34. Malavasi F, Deaglio S, Funaro A, Ferrero E, Horenstein AL, Ortolan E, Vaisitti T, Aydin S,. Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology. Physiol Rev 2008; 88: 841-86.
35. Mathas S, Janz M, Hummel F, Hummel M, Wollert-Wulf B, Lusatis S, Anagnostopoulos I, Lietz A, Sigvardsson M, Jundt F, Johrens K, Bommert K, et al. Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma. Nat Immunol 2006; 7: 207-15. (Pubitemid 43135887)
36. Depoil D, Fleire S, Treanor BL, Weber M, Harwood NE, Marchbank KL, Tybulewicz VL, Batista FD,. CD19 is essential for B cell activation by promoting B cell receptor-antigen microcluster formation in response to membrane-bound ligand. Nat Immunol 2008; 9: 63-72. (Pubitemid 350286205)
37. Teng Y, Takahashi Y, Yamada M, Kurosu T, Koyama T, Miura O, Miki T,. IRF4 negatively regulates proliferation of germinal center B cell-derived Burkitt's lymphoma cell lines and induces differentiation toward plasma cells. Eur J Cell Biol 2007; 86: 581-9. (Pubitemid 47408710)
38. Hertel CB, Zhou XG, Hamilton-Dutoit SJ, Junker S,. Loss of B cell identity correlates with loss of B cell-specific transcription factors in Hodgkin/Reed-Sternberg cells of classical Hodgkin lymphoma. Oncogene 2002; 21: 4908-20.
39. Kwon H, Thierry-Mieg D, Thierry-Mieg J, Kim HP, Oh J, Tunyaplin C, Carotta S, Donovan CE, Goldman ML, Tailor P, Ozato K, Levy DE, et al. Analysis of interleukin-21-induced Prdm1 gene regulation reveals functional cooperation of STAT3 and IRF4 transcription factors. Immunity 2009; 31: 941-52.
40. Van Vlierberghe P, De Weer A, Mestdagh P, Feys T, De Preter K, De Paepe P, Lambein K, Vandesompele J, Van Roy N, Verhasselt B, Poppe B, Speleman F,. Comparison of miRNA profiles of microdissected Hodgkin/Reed-Sternberg cells and Hodgkin cell lines versus CD77+ B-cells reveals a distinct subset of differentially expressed miRNAs. Br J Haematol 2009; 147: 686-90.
41. Gibcus JH, Tan LP, Harms G, Schakel RN, de Jong D, Blokzijl T, Möller P, Poppema S, Kroesen BJ, van den Berg A,. Hodgkin lymphoma cell lines are characterized by a specific miRNA expression profile. Neoplasia 2009; 11: 167-76.
42. Ohkubo Y, Arima M, Arguni E, Okada S, Yamashita K, Asari S, Obata S, Sakamoto A, Hatano M, O-Wang J, Ebara M, Saisho H, et al. A role for c-fos/activator protein 1 in B lymphocyte terminal differentiation. J Immunol 2005; 174: 7703-10. (Pubitemid 40806275)
43. Morgan MA, Magnusdottir E, Kuo TC, Tunyaplin C, Harper J, Arnold SJ, Calame K, Robertson EJ, Bikoff EK,. Blimp-1/Prdm1 alternative promoter usage during mouse development and plasma cell differentiation. Mol Cell Biol 2009; 29: 5813-27.
44. Mathas S, Hinz M, Anagnostopoulos I, Krappmann D, Lietz A, Jundt F, Bommert K, Mechta-Grigoriou F, Stein H, Dorken B, Scheidereit C,. Aberrantly expressed c-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-η B. EMBO J 2002; 21: 4104-13. (Pubitemid 34857442)